Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Plèvre (mésothéliome)
- | Specialty :
- Thérapies Ciblées
Extract
EZH-203 : A Phase 2, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects with Relapsed or Refractory Malignant Mesothelioma with BAP1 Loss of Function.